China is blaming the United States for the origin of COVID-19, accusing Washington of "evading responsibility" for the virus amid multiple statements by President Donald Trump that it was leaked ...

She serves on WHO's Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC) Five years ago, COVID was all we could think about. Today, we’d rather forget about ...

Prasad has long criticized the FDA for granting emergency use authorization for COVID-19 vaccine boosters, saying last year that Marks was "either incompetent or corrupt to authorize a booster ...

To dive deeper into the persistent respiratory symptoms of long COVID, Woodfolk and her team examined extensive clinical and immune datasets from 110 patients at UVA Health's Long COVID Clinic.

Kennedy Jr. to investigate the origins of the Covid-19 pandemic. In an interview Thursday on former Fox News host Megyn Kelly’s podcast, The Megyn Kelly Show, Gabbard also said she wants to end ...

Three children were dramatically rescued from a COVID lockdown house of horrors after being forced for years to stay inside and wear face masks long after pandemic restrictions ended. The siblings ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

The Department of Health and Human Services has transferred $500 million from research into next-generation COVID-19 vaccines, redirecting the money to a single vaccine project linked to the Trump ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug Administration (FDA) says it wants more data before it can be approved.

China pointed its finger at the United States for originating COVID-19 on Wednesday, claiming America was attempting to “shift the blame” after President Trump declared the deadly disease was ...

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...